Pfizer recently announced it is conducting a clinical study to evaluate Caduet (amlodipine besylate and atorvastatin calcium) in treating African-Americans with high blood pressure and high cholesterol.
The study will examine the efficacy of Caduet in helping African-American patients achieve nationally established treatment goals for both conditions.
Heart disease claims more than 100,000 African-American lives each year, Pfizer reported. Forty-five percent of African-American men and 46 percent of African-American women have total blood cholesterol levels that exceed the national guidelines of 200 mg/dL.
COPYRIGHT 2004 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2004 Gale Group
Home
A
Cabergoline
